You are here : ERS ASSEMBLIES Thoracic Oncology Assembly

Thoracic Oncology Assembly

Head: Jean-Paul Sculier
Secretary: Johan Vansteenkiste

Respiratory tumours represent a major part of the daily practice of many respiratory physicians. Our Group focuses on all aspects of these tumours (lung cancer, mesothelioma, mediastinal tumours and lung metastases) including: epidemiology and prevention; biology and pathology; diagnosis and staging; the multidisciplinary approach of therapy; the systemic treatment with chemotherapy and targeted agents; and follow-up and supportive care. There is a close cooperation with Imaging, Interventional Respiratory Medicine, Radiotherapy, Biology and Thoracic Surgery Groups, now formalised into the Thoracic Oncology Network of the ERS.
This Group tries to reinforce the position of the respiratory physician in this important domain of practice in different countries by the organisation of Symposia on contemporary clinical questions, by the organisation of dedicated school courses, by establishing practice guidelines, and by cooperation with other societies.

  • Lung Cancer

     

    Chair: Nicolas Schoenfeld
    Secretary: Fernando Gamarra

    Lung cancer has advanced to the deadliest tumour worldwide. Prevention, diagnosis and therapy of this devastating disease are the main challenges for respiratory physicians. Read more...

  • Pleural and Mediastinal Malignancies

     

    Chair: Arnaud Scherpereel
    Secretary:Bogdan Dragos Grigoriu

    Pleural and mediastinal malignancies are less frequent than lung cancer but represent an important concern in the daily practice of respiratory physicians. In fact, the incidence of malignant pleural mesothelioma (MPM) is growing and this trend will continue for the two next decades in most European countries, linked to previous asbestos exposure, the main aetiological factor of MPM. Moreover, malignant pleural effusions are much more frequent than MPM, and are a common complication of many cancers, like breast and lung cancers.

    Read more...

 

Share facebook Share linkedIn Share twitter
Share rss